ITMI942097A0 - Antagonista della interleuchina-1 - Google Patents

Antagonista della interleuchina-1

Info

Publication number
ITMI942097A0
ITMI942097A0 ITMI942097A ITMI942097A ITMI942097A0 IT MI942097 A0 ITMI942097 A0 IT MI942097A0 IT MI942097 A ITMI942097 A IT MI942097A IT MI942097 A ITMI942097 A IT MI942097A IT MI942097 A0 ITMI942097 A0 IT MI942097A0
Authority
IT
Italy
Prior art keywords
interleukin
antagonist
Prior art date
Application number
ITMI942097A
Other languages
English (en)
Inventor
Francesco Colotta
Maria Muzio
Alberto Mantovani
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ITMI942097A0 publication Critical patent/ITMI942097A0/it
Priority to ITMI942097A priority Critical patent/IT1270662B/it
Priority to US08/476,860 priority patent/US5739282A/en
Priority to PT95936482T priority patent/PT786002E/pt
Priority to BR9509317A priority patent/BR9509317A/pt
Priority to DE69534419T priority patent/DE69534419T2/de
Priority to RU97107461/13A priority patent/RU2193064C2/ru
Priority to CA002202470A priority patent/CA2202470C/en
Priority to KR1019970701931A priority patent/KR100237936B1/ko
Priority to EP95936482A priority patent/EP0786002B1/en
Priority to AT95936482T priority patent/ATE303439T1/de
Priority to ES95936482T priority patent/ES2243942T3/es
Priority to DK95936482T priority patent/DK0786002T3/da
Priority to PCT/EP1995/004023 priority patent/WO1996012022A1/en
Priority to JP8512932A priority patent/JPH10509306A/ja
Priority to CNB200510053993XA priority patent/CN100363053C/zh
Priority to AU38417/95A priority patent/AU701471C/en
Priority to EE9700090A priority patent/EE03697B1/xx
Priority to CNB951956647A priority patent/CN1224707C/zh
Priority to MX9702616A priority patent/MX9702616A/es
Priority to UA97052129A priority patent/UA65522C2/uk
Publication of ITMI942097A1 publication Critical patent/ITMI942097A1/it
Priority to NO19971624A priority patent/NO320494B1/no
Application granted granted Critical
Publication of IT1270662B publication Critical patent/IT1270662B/it
Priority to US08/910,733 priority patent/US5837495A/en
Priority to US08/910,884 priority patent/US5981713A/en
Priority to HK98101565A priority patent/HK1002659A1/xx
Priority to HK06103612A priority patent/HK1081124A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
ITMI942097A 1994-10-13 1994-10-13 Antagonista della interleuchina-1 IT1270662B (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1
US08/476,860 US5739282A (en) 1994-10-13 1995-06-07 Interleukin-1 antagonist
PCT/EP1995/004023 WO1996012022A1 (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist
AU38417/95A AU701471C (en) 1994-10-13 1995-10-12 Interleukin-1 antagonist
DE69534419T DE69534419T2 (de) 1994-10-13 1995-10-12 Intrazelluläre isoform von interleukin-1 rezeptor antagonist
RU97107461/13A RU2193064C2 (ru) 1994-10-13 1995-10-12 Внутриклеточная изоформа антагониста рецептора интерлейкина-1
CA002202470A CA2202470C (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1-receptor antagonist
KR1019970701931A KR100237936B1 (ko) 1994-10-13 1995-10-12 인터루킨-1 길항제
EP95936482A EP0786002B1 (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist
AT95936482T ATE303439T1 (de) 1994-10-13 1995-10-12 Intrazelluläre isoform von interleukin-1 rezeptor antagonist
ES95936482T ES2243942T3 (es) 1994-10-13 1995-10-12 Isoforma intracelular del antagonista del receptor de la interleuquina.
DK95936482T DK0786002T3 (da) 1994-10-13 1995-10-12 Intracellulær isoform af interleukin-1-receptorantagonisten
PT95936482T PT786002E (pt) 1994-10-13 1995-10-12 Isoforma intracelular do antagonista do receptor da interleuquina-1
JP8512932A JPH10509306A (ja) 1994-10-13 1995-10-12 インターロイキン−１レセプターアンタゴニストの細胞内イソ形態
CNB200510053993XA CN100363053C (zh) 1994-10-13 1995-10-12 白细胞介素-1受体拮抗剂的细胞内同种型
BR9509317A BR9509317A (pt) 1994-10-13 1995-10-12 Antagonista a interleucina-1
EE9700090A EE03697B1 (et) 1994-10-13 1995-10-12 Interleukiin-1 retseptori antagonisti intratsellulaarne isovorm
CNB951956647A CN1224707C (zh) 1994-10-13 1995-10-12 白细胞介素－1受体拮抗剂的细胞内同种型
MX9702616A MX9702616A (es) 1994-10-13 1995-10-12 Isoforma intracelular del antagonista receptor de interleucina -1.
UA97052129A UA65522C2 (en) 1994-10-13 1995-12-10 Inner cellular isoform of interleukin-1 receptor antagonist
NO19971624A NO320494B1 (no) 1994-10-13 1997-04-09 Renset protein med antagonistisk aktivitet mot minst en av forbindelsene valgt fra gruppen bestaende av interleukin-1-a og interleikun-1-b, isolert DNA sekvens, vektor, vertscelle, og fremgangsmater og anvendelser derav.
US08/910,733 US5837495A (en) 1994-10-13 1997-08-13 DNA encoding interleukin-1 antagonist
US08/910,884 US5981713A (en) 1994-10-13 1997-08-13 Antibodies to intereleukin-1 antagonists
HK98101565A HK1002659A1 (en) 1994-10-13 1998-02-27 Intracelluilar isoform of the interleukin-1 receptor antagonist
HK06103612A HK1081124A1 (en) 1994-10-13 2006-03-22 Intracellular isoform of the interleukin-1 receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1

Publications (3)

Publication Number Publication Date
ITMI942097A0 true ITMI942097A0 (it) 1994-10-13
ITMI942097A1 ITMI942097A1 (it) 1996-04-13
IT1270662B IT1270662B (it) 1997-05-07

Family

ID=11369705

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1

Country Status (19)

Country Link
US (1) US5739282A (it)
EP (1) EP0786002B1 (it)
JP (1) JPH10509306A (it)
KR (1) KR100237936B1 (it)
CN (2) CN100363053C (it)
AT (1) ATE303439T1 (it)
BR (1) BR9509317A (it)
CA (1) CA2202470C (it)
DE (1) DE69534419T2 (it)
EE (1) EE03697B1 (it)
ES (1) ES2243942T3 (it)
HK (2) HK1002659A1 (it)
IT (1) IT1270662B (it)
MX (1) MX9702616A (it)
NO (1) NO320494B1 (it)
PT (1) PT786002E (it)
RU (1) RU2193064C2 (it)
UA (1) UA65522C2 (it)
WO (1) WO1996012022A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
PT938500E (pt) 1996-10-31 2005-02-28 Applied Research Systems Peptidos inibidores da ice
DE69738948D1 (de) * 1996-12-06 2008-10-09 Amgen Inc Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US7166712B2 (en) * 2000-07-12 2007-01-23 Philadelphia, Health And Education Corporation Mammalian MDM2 binding proteins and uses thereof
ES2533084T3 (es) * 2003-12-23 2015-04-07 Genentech, Inc. Tratamiento del cáncer con anticuerpos monoclonales anti-IL 13 novedosos
EP2327413A1 (en) 2004-07-06 2011-06-01 ZymoGenetics, Inc. Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
WO2009062339A1 (en) 2007-11-14 2009-05-22 General Regeneratives, Ltd. Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
CA2828504A1 (en) 2011-03-14 2012-09-20 Serodus Asa Antagonists of the interleukin-1 receptor
DK2859015T3 (en) 2012-06-08 2018-06-18 Alkermes Inc LIGANDS MODIFIED BY CIRCULAR MODIFICATION AS AGONISTS AND ANTAGONISTS
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
ES2103305T3 (es) * 1989-11-29 1997-09-16 Amgen Boulder Inc Produccion de inhibidor de interleuquina-1 humana recombinada.
AU649245B2 (en) * 1990-04-02 1994-05-19 Amgen, Inc. Methods for treating interleukin-1 mediated diseases
WO1991017184A1 (en) * 1990-04-27 1991-11-14 The Upjohn Company Modified interleukin-1 inhibitors
WO1991017249A1 (en) * 1990-05-01 1991-11-14 Cetus Corporation Interleukin-1 antagonist and uses thereof

Also Published As

Publication number Publication date
NO971624D0 (no) 1997-04-09
EE03697B1 (et) 2002-04-15
EE9700090A (et) 1997-10-15
DE69534419D1 (de) 2005-10-06
NO971624L (no) 1997-05-30
CA2202470A1 (en) 1996-04-25
RU2193064C2 (ru) 2002-11-20
BR9509317A (pt) 1997-10-14
CN100363053C (zh) 2008-01-23
EP0786002B1 (en) 2005-08-31
IT1270662B (it) 1997-05-07
ATE303439T1 (de) 2005-09-15
KR970706391A (ko) 1997-11-03
KR100237936B1 (ko) 2000-01-15
AU701471B2 (en) 1999-01-28
DE69534419T2 (de) 2006-06-14
WO1996012022A1 (en) 1996-04-25
UA65522C2 (en) 2004-04-15
MX9702616A (es) 1998-04-30
CN1224707C (zh) 2005-10-26
US5739282A (en) 1998-04-14
ITMI942097A1 (it) 1996-04-13
JPH10509306A (ja) 1998-09-14
CN1679919A (zh) 2005-10-12
EP0786002A1 (en) 1997-07-30
CN1161058A (zh) 1997-10-01
CA2202470C (en) 2008-09-16
HK1002659A1 (en) 1998-09-11
PT786002E (pt) 2005-11-30
ES2243942T3 (es) 2005-12-01
HK1081124A1 (en) 2006-05-12
NO320494B1 (no) 2005-12-12
AU3841795A (en) 1996-05-06

Similar Documents

Publication Publication Date Title
BR9502236A (pt) Dispositivo elétrico
ITMI942097A0 (it) Antagonista della interleuchina-1
DE69728231D1 (de) Firststruktur
KR970054862U (ko) 항타기의 리더구조
KR950029331U (ko) 침대 겸용 소파
DE29615621U1 (de) Eßlöffel
KR950025210U (ko) 건축용 연결부재 구조
DE9416307U1 (de) Prüfvorrichtung
KR950027351U (ko) 반목 항타장치
KR960016562U (ko) 전극고정치구
DE29500356U1 (de) Probennehmer
DE9400302U1 (de) Kinderstuhl
DE9412886U1 (de) Bügelsäge
KR960012685U (ko) 씨모오스 구조
KR960006219U (ko) 측정대구조
KR960011163U (ko) 단열재 고정기구
KR960011162U (ko) 단열재 고정기구
DE29603485U1 (de) Baukörper
NO962890D0 (no) Brokonstruksjon
ITUD960033V0 (it) Struttura antisfalcio
ITUD960189A3 (it) Struttura antisfalcio
KR960003817U (ko) 가구조립용 블록
DE29723784U1 (de) Esslöffel
DE9408370U1 (de) Prüfvorrichtung
DE9415829U1 (de) Prüfvorrichtung

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030